 | |
| Company type | Public |
|---|---|
| BSE: 500660 NSE: GLAXO | |
| Industry | Pharmaceuticals & healthcare |
| Founded | 13 November 1924 as H. J. Foster & Co. Limited [1] |
| Headquarters | , India |
| Products | Medicines and vaccines |
| Revenue |  ₹3,723 crore (US$440 million) (2025) |
| ₹1,169 crore (US$140 million) (2025) | |
| ₹915 crore (US$110 million) (2025) | |
Number of employees | 3,100 (2025) [2] |
| Parent | GSK |
| Website | india-pharma |
| Footnotes /references Financials as of 31 March 2025 [update] . [3] | |
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. [4] [5] The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. [6]
